8Helfenstein U,Schtfler G,Bopp M,et al. Exploration of in- teractions between prognostic factors of stage I malignant melanoma [J].Melanoma Res, 1996,6(4):319-324.
9Austin PF,Cmse CW, Lyman G,et al. Age as a prognostic factor in the malignant melanoma population[J]. Ann Surg Oncol, 2011,1 (6):487-494.
10Massi D,Borgognoni L,Franchi A,et al. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors [J]. Melanoma Res, 2000,10(2): 153-164.
8KLAGSBRUN M, TAKASHIMA S, MAMLUK R. The role of neuropilin in vascular and tumor biology [J]. Adv Exp Med Biol, 2002, 515: 33-48.
9SOKER S, MIAO H Q, NOMI M, et al. VEGF165 Mediates for- mation of complexes containing VEGFR-2 and neuropilin-I that enhance VEGF165-receptor binding [ J]. Cell Biochem, 2002, 85 ( 2 ) : 357-368.
10BECKER P M, WALTENBERGER J, YACHECHKO R, et al. Neuropilin-I regulates vascular endothelial growth factor-mediated endothelial permeability [ J ]. Circ Res, 2005, 96 (12) : 1257- 1265.